Stay updated on 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.

Latest updates to the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page
- Check7 days agoChange DetectedThe related topics section now excludes 'Multiple myeloma' and 'MedlinePlus Genetics' from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check14 days agoChange DetectedRevision: v3.4.2 is now displayed; prior notices about government funding and operating status were removed.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a site-wide funding notice about government funding lapses and an operating status update. Included a related topic tag for Multiple myeloma and updated the revision history to v3.4.1 while removing v3.4.0.SummaryDifference0.6%

- Check28 days agoChange DetectedThe page now shows a glossary and adds the 'Last Update Submitted that Met QC Criteria' indicator, plus a revision note 'Revision: v3.4.0'. It also removes certain related topics and older QC labels such as 'MedlinePlus Genetics', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.4%

- Check42 days agoChange DetectedRelated topics were added (MedlinePlus Genetics and a Multiple Myeloma tag). The page revision updated from v3.3.3 to v3.3.4.SummaryDifference0.2%

- Check64 days agoChange DetectedAdded the Locations section with New York as a study site. Removed the related topic New York Locations and other ancillary topics to reflect updated content.SummaryDifference0.4%

Stay in the know with updates to 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.